nodes	percent_of_prediction	percent_of_DWPC	metapath
Neostigmine—BCHE—obesity	0.618	1	CbGaD
Neostigmine—BCHE—diaphragm—obesity	0.00968	0.418	CbGeAlD
Neostigmine—Demecarium—BCHE—obesity	0.00277	0.376	CrCbGaD
Neostigmine—ACHE—islet of Langerhans—obesity	0.00238	0.103	CbGeAlD
Neostigmine—Pyridostigmine—BCHE—obesity	0.00178	0.242	CrCbGaD
Neostigmine—Edrophonium—BCHE—obesity	0.00145	0.198	CrCbGaD
Neostigmine—ACHE—adrenal gland—obesity	0.00136	0.0588	CbGeAlD
Neostigmine—Rivastigmine—BCHE—obesity	0.00135	0.184	CrCbGaD
Neostigmine—Gastrointestinal disorder—Benzphetamine—obesity	0.00115	0.00568	CcSEcCtD
Neostigmine—Dysarthria—Bupropion—obesity	0.00114	0.0056	CcSEcCtD
Neostigmine—Agitation—Phentermine—obesity	0.00112	0.00552	CcSEcCtD
Neostigmine—BCHE—respiratory system—obesity	0.0011	0.0477	CbGeAlD
Neostigmine—Insomnia—Phendimetrazine—obesity	0.0011	0.00542	CcSEcCtD
Neostigmine—Urticaria—Methamphetamine—obesity	0.0011	0.00542	CcSEcCtD
Neostigmine—Arrhythmia—Diethylpropion—obesity	0.00109	0.00536	CcSEcCtD
Neostigmine—Urticaria—Benzphetamine—obesity	0.00106	0.00522	CcSEcCtD
Neostigmine—Salivary hypersecretion—Bupropion—obesity	0.00104	0.00514	CcSEcCtD
Neostigmine—Wheezing—Bupropion—obesity	0.00104	0.00514	CcSEcCtD
Neostigmine—Urinary incontinence—Bupropion—obesity	0.00104	0.00511	CcSEcCtD
Neostigmine—Hypersensitivity—Methamphetamine—obesity	0.00102	0.00502	CcSEcCtD
Neostigmine—Dry mouth—Phentermine—obesity	0.00102	0.005	CcSEcCtD
Neostigmine—Tachycardia—Phenylpropanolamine—obesity	0.00101	0.005	CcSEcCtD
Neostigmine—Flatulence—Cimetidine—obesity	0.000995	0.0049	CcSEcCtD
Neostigmine—Hypersensitivity—Benzphetamine—obesity	0.000984	0.00484	CcSEcCtD
Neostigmine—Coma—Bupropion—obesity	0.000983	0.00484	CcSEcCtD
Neostigmine—Agitation—Diethylpropion—obesity	0.000975	0.0048	CcSEcCtD
Neostigmine—Hypotension—Phenylpropanolamine—obesity	0.000972	0.00478	CcSEcCtD
Neostigmine—Tachycardia—Phentermine—obesity	0.000971	0.00478	CcSEcCtD
Neostigmine—Abdominal pain—Phendimetrazine—obesity	0.000962	0.00474	CcSEcCtD
Neostigmine—Nystagmus—Topiramate—obesity	0.000959	0.00472	CcSEcCtD
Neostigmine—Diarrhoea—Methamphetamine—obesity	0.000948	0.00466	CcSEcCtD
Neostigmine—Insomnia—Phenylpropanolamine—obesity	0.000941	0.00463	CcSEcCtD
Neostigmine—Agitation—Cimetidine—obesity	0.000927	0.00457	CcSEcCtD
Neostigmine—Dyspnoea—Phenylpropanolamine—obesity	0.000927	0.00456	CcSEcCtD
Neostigmine—Osteoarthritis—Orlistat—obesity	0.000925	0.00455	CcSEcCtD
Neostigmine—Somnolence—Phenylpropanolamine—obesity	0.000924	0.00455	CcSEcCtD
Neostigmine—Convulsion—Diethylpropion—obesity	0.000919	0.00452	CcSEcCtD
Neostigmine—Dizziness—Methamphetamine—obesity	0.000916	0.00451	CcSEcCtD
Neostigmine—Diarrhoea—Benzphetamine—obesity	0.000914	0.0045	CcSEcCtD
Neostigmine—Insomnia—Phentermine—obesity	0.0009	0.00443	CcSEcCtD
Neostigmine—Osteoarthritis—Sibutramine—obesity	0.000895	0.00441	CcSEcCtD
Neostigmine—Dizziness—Benzphetamine—obesity	0.000883	0.00435	CcSEcCtD
Neostigmine—Dry mouth—Diethylpropion—obesity	0.000883	0.00435	CcSEcCtD
Neostigmine—Headache—Methamphetamine—obesity	0.000868	0.00427	CcSEcCtD
Neostigmine—Arthralgia—Cimetidine—obesity	0.000859	0.00423	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Phentermine—obesity	0.000859	0.00423	CcSEcCtD
Neostigmine—Cardiac arrest—Sibutramine—obesity	0.000851	0.00419	CcSEcCtD
Neostigmine—BCHE—cardiovascular system—obesity	0.000846	0.0365	CbGeAlD
Neostigmine—Tachycardia—Diethylpropion—obesity	0.000845	0.00416	CcSEcCtD
Neostigmine—Hyperhidrosis—Diethylpropion—obesity	0.000837	0.00412	CcSEcCtD
Neostigmine—Headache—Benzphetamine—obesity	0.000837	0.00412	CcSEcCtD
Neostigmine—Cramp muscle—Orlistat—obesity	0.000833	0.0041	CcSEcCtD
Neostigmine—Diarrhoea—Phendimetrazine—obesity	0.000833	0.0041	CcSEcCtD
Neostigmine—Anaphylactic shock—Cimetidine—obesity	0.000824	0.00405	CcSEcCtD
Neostigmine—Dizziness—Phendimetrazine—obesity	0.000805	0.00396	CcSEcCtD
Neostigmine—Tachycardia—Cimetidine—obesity	0.000804	0.00396	CcSEcCtD
Neostigmine—Nausea—Benzphetamine—obesity	0.000793	0.0039	CcSEcCtD
Neostigmine—Urticaria—Phentermine—obesity	0.000791	0.00389	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Diethylpropion—obesity	0.000789	0.00388	CcSEcCtD
Neostigmine—Abdominal pain—Phentermine—obesity	0.000787	0.00387	CcSEcCtD
Neostigmine—Bronchospasm—Orlistat—obesity	0.000787	0.00387	CcSEcCtD
Neostigmine—Insomnia—Diethylpropion—obesity	0.000783	0.00385	CcSEcCtD
Neostigmine—Osteoarthritis—Bupropion—obesity	0.000781	0.00384	CcSEcCtD
Neostigmine—Cardiovascular disorder—Topiramate—obesity	0.00078	0.00384	CcSEcCtD
Neostigmine—Sweating increased—Orlistat—obesity	0.000779	0.00383	CcSEcCtD
Neostigmine—Dyspnoea—Diethylpropion—obesity	0.000772	0.0038	CcSEcCtD
Neostigmine—Somnolence—Diethylpropion—obesity	0.00077	0.00379	CcSEcCtD
Neostigmine—Hypersensitivity—Phenylpropanolamine—obesity	0.000766	0.00377	CcSEcCtD
Neostigmine—Headache—Phendimetrazine—obesity	0.000763	0.00375	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Cimetidine—obesity	0.00075	0.00369	CcSEcCtD
Neostigmine—BCHE—pituitary gland—obesity	0.000749	0.0323	CbGeAlD
Neostigmine—Gastrointestinal disorder—Diethylpropion—obesity	0.000747	0.00368	CcSEcCtD
Neostigmine—BCHE—adipose tissue—obesity	0.000746	0.0322	CbGeAlD
Neostigmine—Lacrimation increased—Topiramate—obesity	0.000743	0.00366	CcSEcCtD
Neostigmine—Somnolence—Cimetidine—obesity	0.000732	0.0036	CcSEcCtD
Neostigmine—Dysarthria—Topiramate—obesity	0.000724	0.00357	CcSEcCtD
Neostigmine—Nausea—Phendimetrazine—obesity	0.000723	0.00356	CcSEcCtD
Neostigmine—Pollakiuria—Sibutramine—obesity	0.000715	0.00352	CcSEcCtD
Neostigmine—Asthenia—Phentermine—obesity	0.000714	0.00351	CcSEcCtD
Neostigmine—Atrioventricular block—Topiramate—obesity	0.000706	0.00348	CcSEcCtD
Neostigmine—Cramp muscle—Bupropion—obesity	0.000703	0.00346	CcSEcCtD
Neostigmine—BCHE—digestive system—obesity	0.000702	0.0303	CbGeAlD
Neostigmine—Urticaria—Diethylpropion—obesity	0.000688	0.00339	CcSEcCtD
Neostigmine—Dizziness—Phenylpropanolamine—obesity	0.000688	0.00338	CcSEcCtD
Neostigmine—Diarrhoea—Phentermine—obesity	0.000681	0.00335	CcSEcCtD
Neostigmine—BCHE—adrenal gland—obesity	0.000669	0.0289	CbGeAlD
Neostigmine—Salivary hypersecretion—Topiramate—obesity	0.000665	0.00328	CcSEcCtD
Neostigmine—Bronchospasm—Bupropion—obesity	0.000664	0.00327	CcSEcCtD
Neostigmine—Urinary incontinence—Topiramate—obesity	0.000662	0.00326	CcSEcCtD
Neostigmine—Vomiting—Phenylpropanolamine—obesity	0.000661	0.00325	CcSEcCtD
Neostigmine—Dizziness—Phentermine—obesity	0.000658	0.00324	CcSEcCtD
Neostigmine—Sweating increased—Bupropion—obesity	0.000657	0.00323	CcSEcCtD
Neostigmine—Rash—Phenylpropanolamine—obesity	0.000656	0.00323	CcSEcCtD
Neostigmine—Dermatitis—Phenylpropanolamine—obesity	0.000655	0.00322	CcSEcCtD
Neostigmine—Vomiting—Phentermine—obesity	0.000633	0.00311	CcSEcCtD
Neostigmine—Urinary tract disorder—Orlistat—obesity	0.000632	0.00311	CcSEcCtD
Neostigmine—Bradycardia—Sibutramine—obesity	0.000631	0.0031	CcSEcCtD
Neostigmine—Urethral disorder—Orlistat—obesity	0.000627	0.00309	CcSEcCtD
Neostigmine—Rash—Phentermine—obesity	0.000627	0.00309	CcSEcCtD
Neostigmine—Dermatitis—Phentermine—obesity	0.000627	0.00309	CcSEcCtD
Neostigmine—Headache—Phentermine—obesity	0.000623	0.00307	CcSEcCtD
Neostigmine—Pollakiuria—Bupropion—obesity	0.000623	0.00307	CcSEcCtD
Neostigmine—Nausea—Phenylpropanolamine—obesity	0.000618	0.00304	CcSEcCtD
Neostigmine—Hypersensitivity—Cimetidine—obesity	0.000607	0.00299	CcSEcCtD
Neostigmine—Diarrhoea—Diethylpropion—obesity	0.000592	0.00292	CcSEcCtD
Neostigmine—Nausea—Phentermine—obesity	0.000591	0.00291	CcSEcCtD
Neostigmine—Asthenia—Cimetidine—obesity	0.000591	0.00291	CcSEcCtD
Neostigmine—BCHE—endocrine gland—obesity	0.00058	0.0251	CbGeAlD
Neostigmine—Mediastinal disorder—Orlistat—obesity	0.000577	0.00284	CcSEcCtD
Neostigmine—Dizziness—Diethylpropion—obesity	0.000572	0.00282	CcSEcCtD
Neostigmine—Diarrhoea—Cimetidine—obesity	0.000564	0.00277	CcSEcCtD
Neostigmine—Mental disorder—Orlistat—obesity	0.000561	0.00276	CcSEcCtD
Neostigmine—ABCB1—islet of Langerhans—obesity	0.000558	0.0241	CbGeAlD
Neostigmine—Arrhythmia—Sibutramine—obesity	0.000553	0.00272	CcSEcCtD
Neostigmine—Vomiting—Diethylpropion—obesity	0.00055	0.00271	CcSEcCtD
Neostigmine—Flatulence—Orlistat—obesity	0.000549	0.0027	CcSEcCtD
Neostigmine—Rash—Diethylpropion—obesity	0.000546	0.00269	CcSEcCtD
Neostigmine—Dermatitis—Diethylpropion—obesity	0.000545	0.00268	CcSEcCtD
Neostigmine—Dizziness—Cimetidine—obesity	0.000545	0.00268	CcSEcCtD
Neostigmine—Headache—Diethylpropion—obesity	0.000542	0.00267	CcSEcCtD
Neostigmine—Muscle spasms—Orlistat—obesity	0.000536	0.00264	CcSEcCtD
Neostigmine—Urinary tract disorder—Bupropion—obesity	0.000533	0.00263	CcSEcCtD
Neostigmine—Flatulence—Sibutramine—obesity	0.000531	0.00262	CcSEcCtD
Neostigmine—Connective tissue disorder—Bupropion—obesity	0.000531	0.00261	CcSEcCtD
Neostigmine—Urethral disorder—Bupropion—obesity	0.000529	0.00261	CcSEcCtD
Neostigmine—ABCB1—respiratory system—obesity	0.000527	0.0227	CbGeAlD
Neostigmine—Vomiting—Cimetidine—obesity	0.000524	0.00258	CcSEcCtD
Neostigmine—BCHE—liver—obesity	0.000523	0.0226	CbGeAlD
Neostigmine—Rash—Cimetidine—obesity	0.000519	0.00256	CcSEcCtD
Neostigmine—Dermatitis—Cimetidine—obesity	0.000519	0.00255	CcSEcCtD
Neostigmine—Muscle spasms—Sibutramine—obesity	0.000518	0.00255	CcSEcCtD
Neostigmine—Headache—Cimetidine—obesity	0.000516	0.00254	CcSEcCtD
Neostigmine—Nausea—Diethylpropion—obesity	0.000514	0.00253	CcSEcCtD
Neostigmine—Flushing—Bupropion—obesity	0.000501	0.00247	CcSEcCtD
Neostigmine—Osteoarthritis—Topiramate—obesity	0.000497	0.00245	CcSEcCtD
Neostigmine—Agitation—Sibutramine—obesity	0.000496	0.00244	CcSEcCtD
Neostigmine—Nausea—Cimetidine—obesity	0.000489	0.00241	CcSEcCtD
Neostigmine—Mediastinal disorder—Bupropion—obesity	0.000487	0.0024	CcSEcCtD
Neostigmine—Syncope—Sibutramine—obesity	0.000484	0.00238	CcSEcCtD
Neostigmine—Convulsion—Orlistat—obesity	0.000483	0.00238	CcSEcCtD
Neostigmine—Arrhythmia—Bupropion—obesity	0.000482	0.00237	CcSEcCtD
Neostigmine—Loss of consciousness—Sibutramine—obesity	0.000474	0.00233	CcSEcCtD
Neostigmine—Mental disorder—Bupropion—obesity	0.000473	0.00233	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000471	0.00232	CcSEcCtD
Neostigmine—Convulsion—Sibutramine—obesity	0.000467	0.0023	CcSEcCtD
Neostigmine—Dry mouth—Orlistat—obesity	0.000464	0.00228	CcSEcCtD
Neostigmine—Flatulence—Bupropion—obesity	0.000463	0.00228	CcSEcCtD
Neostigmine—Arthralgia—Sibutramine—obesity	0.000459	0.00226	CcSEcCtD
Neostigmine—Anaphylactic shock—Orlistat—obesity	0.000455	0.00224	CcSEcCtD
Neostigmine—Muscle spasms—Bupropion—obesity	0.000452	0.00222	CcSEcCtD
Neostigmine—Dry mouth—Sibutramine—obesity	0.000449	0.00221	CcSEcCtD
Neostigmine—Nervous system disorder—Orlistat—obesity	0.000446	0.0022	CcSEcCtD
Neostigmine—ABCB1—adrenal cortex—obesity	0.000442	0.0191	CbGeAlD
Neostigmine—Skin disorder—Orlistat—obesity	0.000442	0.00217	CcSEcCtD
Neostigmine—Anaphylactic shock—Sibutramine—obesity	0.00044	0.00217	CcSEcCtD
Neostigmine—Hyperhidrosis—Orlistat—obesity	0.00044	0.00216	CcSEcCtD
Neostigmine—Shock—Sibutramine—obesity	0.000433	0.00213	CcSEcCtD
Neostigmine—Agitation—Bupropion—obesity	0.000432	0.00213	CcSEcCtD
Neostigmine—Tachycardia—Sibutramine—obesity	0.00043	0.00211	CcSEcCtD
Neostigmine—Skin disorder—Sibutramine—obesity	0.000427	0.0021	CcSEcCtD
Neostigmine—Hyperhidrosis—Sibutramine—obesity	0.000425	0.00209	CcSEcCtD
Neostigmine—Syncope—Bupropion—obesity	0.000422	0.00208	CcSEcCtD
Neostigmine—Sweating increased—Topiramate—obesity	0.000419	0.00206	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Orlistat—obesity	0.000414	0.00204	CcSEcCtD
Neostigmine—Loss of consciousness—Bupropion—obesity	0.000413	0.00203	CcSEcCtD
Neostigmine—Insomnia—Orlistat—obesity	0.000411	0.00202	CcSEcCtD
Neostigmine—Hypotension—Sibutramine—obesity	0.000411	0.00202	CcSEcCtD
Neostigmine—Convulsion—Bupropion—obesity	0.000407	0.002	CcSEcCtD
Neostigmine—ABCB1—cardiovascular system—obesity	0.000403	0.0174	CbGeAlD
Neostigmine—Musculoskeletal discomfort—Sibutramine—obesity	0.000401	0.00197	CcSEcCtD
Neostigmine—Arthralgia—Bupropion—obesity	0.0004	0.00197	CcSEcCtD
Neostigmine—Insomnia—Sibutramine—obesity	0.000398	0.00196	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000397	0.00196	CcSEcCtD
Neostigmine—Pollakiuria—Topiramate—obesity	0.000397	0.00195	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Orlistat—obesity	0.000393	0.00193	CcSEcCtD
Neostigmine—Dyspnoea—Sibutramine—obesity	0.000392	0.00193	CcSEcCtD
Neostigmine—Dry mouth—Bupropion—obesity	0.000391	0.00193	CcSEcCtD
Neostigmine—Somnolence—Sibutramine—obesity	0.000391	0.00193	CcSEcCtD
Neostigmine—Anaphylactic shock—Bupropion—obesity	0.000384	0.00189	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Sibutramine—obesity	0.00038	0.00187	CcSEcCtD
Neostigmine—Shock—Bupropion—obesity	0.000377	0.00186	CcSEcCtD
Neostigmine—Nervous system disorder—Bupropion—obesity	0.000376	0.00185	CcSEcCtD
Neostigmine—Tachycardia—Bupropion—obesity	0.000374	0.00184	CcSEcCtD
Neostigmine—Skin disorder—Bupropion—obesity	0.000373	0.00183	CcSEcCtD
Neostigmine—Gastrointestinal pain—Orlistat—obesity	0.000372	0.00183	CcSEcCtD
Neostigmine—Hyperhidrosis—Bupropion—obesity	0.000371	0.00183	CcSEcCtD
Neostigmine—Urticaria—Orlistat—obesity	0.000361	0.00178	CcSEcCtD
Neostigmine—Gastrointestinal pain—Sibutramine—obesity	0.00036	0.00177	CcSEcCtD
Neostigmine—Abdominal pain—Orlistat—obesity	0.000359	0.00177	CcSEcCtD
Neostigmine—Hypotension—Bupropion—obesity	0.000359	0.00176	CcSEcCtD
Neostigmine—ABCB1—pituitary gland—obesity	0.000357	0.0154	CbGeAlD
Neostigmine—ABCB1—adipose tissue—obesity	0.000356	0.0154	CbGeAlD
Neostigmine—Bradycardia—Topiramate—obesity	0.00035	0.00172	CcSEcCtD
Neostigmine—Urticaria—Sibutramine—obesity	0.00035	0.00172	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Bupropion—obesity	0.00035	0.00172	CcSEcCtD
Neostigmine—Abdominal pain—Sibutramine—obesity	0.000348	0.00171	CcSEcCtD
Neostigmine—Insomnia—Bupropion—obesity	0.000347	0.00171	CcSEcCtD
Neostigmine—Dyspnoea—Bupropion—obesity	0.000342	0.00168	CcSEcCtD
Neostigmine—Somnolence—Bupropion—obesity	0.000341	0.00168	CcSEcCtD
Neostigmine—Urinary tract disorder—Topiramate—obesity	0.00034	0.00167	CcSEcCtD
Neostigmine—Connective tissue disorder—Topiramate—obesity	0.000338	0.00166	CcSEcCtD
Neostigmine—Urethral disorder—Topiramate—obesity	0.000337	0.00166	CcSEcCtD
Neostigmine—Hypersensitivity—Orlistat—obesity	0.000335	0.00165	CcSEcCtD
Neostigmine—ABCB1—digestive system—obesity	0.000335	0.0145	CbGeAlD
Neostigmine—Gastrointestinal disorder—Bupropion—obesity	0.000331	0.00163	CcSEcCtD
Neostigmine—Asthenia—Orlistat—obesity	0.000326	0.00161	CcSEcCtD
Neostigmine—Hypersensitivity—Sibutramine—obesity	0.000324	0.0016	CcSEcCtD
Neostigmine—Pruritus—Orlistat—obesity	0.000322	0.00158	CcSEcCtD
Neostigmine—Flushing—Topiramate—obesity	0.000319	0.00157	CcSEcCtD
Neostigmine—ABCB1—adrenal gland—obesity	0.000319	0.0138	CbGeAlD
Neostigmine—Asthenia—Sibutramine—obesity	0.000316	0.00155	CcSEcCtD
Neostigmine—Gastrointestinal pain—Bupropion—obesity	0.000314	0.00154	CcSEcCtD
Neostigmine—Pruritus—Sibutramine—obesity	0.000311	0.00153	CcSEcCtD
Neostigmine—Diarrhoea—Orlistat—obesity	0.000311	0.00153	CcSEcCtD
Neostigmine—Mediastinal disorder—Topiramate—obesity	0.00031	0.00153	CcSEcCtD
Neostigmine—Urticaria—Bupropion—obesity	0.000305	0.0015	CcSEcCtD
Neostigmine—Abdominal pain—Bupropion—obesity	0.000303	0.00149	CcSEcCtD
Neostigmine—Mental disorder—Topiramate—obesity	0.000301	0.00148	CcSEcCtD
Neostigmine—Diarrhoea—Sibutramine—obesity	0.000301	0.00148	CcSEcCtD
Neostigmine—Dizziness—Orlistat—obesity	0.000301	0.00148	CcSEcCtD
Neostigmine—Flatulence—Topiramate—obesity	0.000295	0.00145	CcSEcCtD
Neostigmine—Dizziness—Sibutramine—obesity	0.000291	0.00143	CcSEcCtD
Neostigmine—Vomiting—Orlistat—obesity	0.000289	0.00142	CcSEcCtD
Neostigmine—Muscle spasms—Topiramate—obesity	0.000288	0.00142	CcSEcCtD
Neostigmine—Rash—Orlistat—obesity	0.000287	0.00141	CcSEcCtD
Neostigmine—Dermatitis—Orlistat—obesity	0.000286	0.00141	CcSEcCtD
Neostigmine—Headache—Orlistat—obesity	0.000285	0.0014	CcSEcCtD
Neostigmine—Hypersensitivity—Bupropion—obesity	0.000283	0.00139	CcSEcCtD
Neostigmine—Vomiting—Sibutramine—obesity	0.00028	0.00138	CcSEcCtD
Neostigmine—Rash—Sibutramine—obesity	0.000277	0.00137	CcSEcCtD
Neostigmine—Dermatitis—Sibutramine—obesity	0.000277	0.00136	CcSEcCtD
Neostigmine—ABCB1—endocrine gland—obesity	0.000277	0.0119	CbGeAlD
Neostigmine—Headache—Sibutramine—obesity	0.000276	0.00136	CcSEcCtD
Neostigmine—Asthenia—Bupropion—obesity	0.000275	0.00135	CcSEcCtD
Neostigmine—Agitation—Topiramate—obesity	0.000275	0.00135	CcSEcCtD
Neostigmine—Pruritus—Bupropion—obesity	0.000271	0.00134	CcSEcCtD
Neostigmine—Nausea—Orlistat—obesity	0.00027	0.00133	CcSEcCtD
Neostigmine—Syncope—Topiramate—obesity	0.000269	0.00132	CcSEcCtD
Neostigmine—Loss of consciousness—Topiramate—obesity	0.000263	0.0013	CcSEcCtD
Neostigmine—Diarrhoea—Bupropion—obesity	0.000263	0.00129	CcSEcCtD
Neostigmine—Nausea—Sibutramine—obesity	0.000261	0.00129	CcSEcCtD
Neostigmine—Convulsion—Topiramate—obesity	0.00026	0.00128	CcSEcCtD
Neostigmine—Arthralgia—Topiramate—obesity	0.000255	0.00126	CcSEcCtD
Neostigmine—Dizziness—Bupropion—obesity	0.000254	0.00125	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000253	0.00125	CcSEcCtD
Neostigmine—ABCB1—liver—obesity	0.000249	0.0108	CbGeAlD
Neostigmine—Dry mouth—Topiramate—obesity	0.000249	0.00123	CcSEcCtD
Neostigmine—Vomiting—Bupropion—obesity	0.000244	0.0012	CcSEcCtD
Neostigmine—Rash—Bupropion—obesity	0.000242	0.00119	CcSEcCtD
Neostigmine—Dermatitis—Bupropion—obesity	0.000242	0.00119	CcSEcCtD
Neostigmine—Shock—Topiramate—obesity	0.00024	0.00118	CcSEcCtD
Neostigmine—Headache—Bupropion—obesity	0.00024	0.00118	CcSEcCtD
Neostigmine—Nervous system disorder—Topiramate—obesity	0.00024	0.00118	CcSEcCtD
Neostigmine—Tachycardia—Topiramate—obesity	0.000239	0.00117	CcSEcCtD
Neostigmine—Skin disorder—Topiramate—obesity	0.000237	0.00117	CcSEcCtD
Neostigmine—Hyperhidrosis—Topiramate—obesity	0.000236	0.00116	CcSEcCtD
Neostigmine—Hypotension—Topiramate—obesity	0.000228	0.00112	CcSEcCtD
Neostigmine—Nausea—Bupropion—obesity	0.000228	0.00112	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Topiramate—obesity	0.000223	0.0011	CcSEcCtD
Neostigmine—Insomnia—Topiramate—obesity	0.000221	0.00109	CcSEcCtD
Neostigmine—Dyspnoea—Topiramate—obesity	0.000218	0.00107	CcSEcCtD
Neostigmine—Somnolence—Topiramate—obesity	0.000217	0.00107	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Topiramate—obesity	0.000211	0.00104	CcSEcCtD
Neostigmine—Gastrointestinal pain—Topiramate—obesity	0.0002	0.000984	CcSEcCtD
Neostigmine—Urticaria—Topiramate—obesity	0.000194	0.000956	CcSEcCtD
Neostigmine—Abdominal pain—Topiramate—obesity	0.000193	0.000951	CcSEcCtD
Neostigmine—Hypersensitivity—Topiramate—obesity	0.00018	0.000886	CcSEcCtD
Neostigmine—Asthenia—Topiramate—obesity	0.000175	0.000863	CcSEcCtD
Neostigmine—Pruritus—Topiramate—obesity	0.000173	0.000851	CcSEcCtD
Neostigmine—Diarrhoea—Topiramate—obesity	0.000167	0.000823	CcSEcCtD
Neostigmine—Dizziness—Topiramate—obesity	0.000162	0.000796	CcSEcCtD
Neostigmine—Vomiting—Topiramate—obesity	0.000155	0.000765	CcSEcCtD
Neostigmine—Rash—Topiramate—obesity	0.000154	0.000759	CcSEcCtD
Neostigmine—Dermatitis—Topiramate—obesity	0.000154	0.000758	CcSEcCtD
Neostigmine—Headache—Topiramate—obesity	0.000153	0.000754	CcSEcCtD
Neostigmine—Nausea—Topiramate—obesity	0.000145	0.000715	CcSEcCtD
Neostigmine—ACHE—Metabolism—CETP—obesity	3.48e-05	0.000234	CbGpPWpGaD
Neostigmine—ABCB1—HIF-1-alpha transcription factor network—AKT1—obesity	3.48e-05	0.000234	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—SDC1—obesity	3.44e-05	0.000231	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—MUT—obesity	3.44e-05	0.000231	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—LIPE—obesity	3.44e-05	0.000231	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PRKAR2B—obesity	3.42e-05	0.00023	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—obesity	3.41e-05	0.000229	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—DCN—obesity	3.39e-05	0.000228	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—AKR1C3—obesity	3.38e-05	0.000227	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—F2—obesity	3.37e-05	0.000227	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—GCK—obesity	3.35e-05	0.000225	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—obesity	3.33e-05	0.000224	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—SCARB1—obesity	3.33e-05	0.000224	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CPT1A—obesity	3.3e-05	0.000222	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—DGAT1—obesity	3.3e-05	0.000221	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYB5A—obesity	3.3e-05	0.000221	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—obesity	3.28e-05	0.000221	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—AGT—obesity	3.26e-05	0.000219	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—ALB—obesity	3.24e-05	0.000218	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—NAMPT—obesity	3.24e-05	0.000217	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—SREBF1—obesity	3.23e-05	0.000217	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—CETP—obesity	3.23e-05	0.000217	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PPARG—obesity	3.22e-05	0.000216	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—LIPC—obesity	3.22e-05	0.000216	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GCK—obesity	3.22e-05	0.000216	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—APOC3—obesity	3.2e-05	0.000215	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—TF—obesity	3.2e-05	0.000215	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—LEP—obesity	3.19e-05	0.000214	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ACLY—obesity	3.17e-05	0.000213	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—POMC—obesity	3.17e-05	0.000213	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GOT2—obesity	3.14e-05	0.000211	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—obesity	3.11e-05	0.000209	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CETP—obesity	3.1e-05	0.000208	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3R1—obesity	3.1e-05	0.000208	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—FASN—obesity	3.08e-05	0.000207	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—POMC—obesity	3.07e-05	0.000206	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—SDC1—obesity	3.07e-05	0.000206	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—BCHE—obesity	3.06e-05	0.000206	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ENPP1—obesity	3.06e-05	0.000206	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ALOX12—obesity	3.06e-05	0.000206	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—TFRC—obesity	3.06e-05	0.000206	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—INS—obesity	3.06e-05	0.000205	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—AKR1C3—obesity	3.02e-05	0.000203	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—F2—obesity	3.01e-05	0.000202	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—CCL2—obesity	3.01e-05	0.000202	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—SCARB1—obesity	2.97e-05	0.0002	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—HMGCS1—obesity	2.97e-05	0.000199	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—obesity	2.96e-05	0.000199	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CYP2E1—obesity	2.96e-05	0.000199	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—IGF1—obesity	2.96e-05	0.000199	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—obesity	2.93e-05	0.000197	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—NQO1—obesity	2.92e-05	0.000196	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—ALB—obesity	2.89e-05	0.000194	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—SREBF1—obesity	2.88e-05	0.000194	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ANGPTL4—obesity	2.88e-05	0.000194	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PLIN1—obesity	2.88e-05	0.000194	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PFKFB3—obesity	2.88e-05	0.000194	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PNPLA2—obesity	2.88e-05	0.000194	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SAT1—obesity	2.88e-05	0.000194	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ACADM—obesity	2.88e-05	0.000194	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—obesity	2.86e-05	0.000192	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—obesity	2.84e-05	0.000191	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GOT2—obesity	2.81e-05	0.000188	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—SLC2A4—obesity	2.8e-05	0.000188	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GCG—obesity	2.8e-05	0.000188	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ACACB—obesity	2.8e-05	0.000188	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYTB—obesity	2.8e-05	0.000188	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—OXCT1—obesity	2.8e-05	0.000188	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3R1—obesity	2.77e-05	0.000186	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CYCS—obesity	2.77e-05	0.000186	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—FASN—obesity	2.75e-05	0.000184	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—POMC—obesity	2.74e-05	0.000184	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PNLIP—obesity	2.73e-05	0.000184	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SRD5A1—obesity	2.73e-05	0.000184	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—INS—obesity	2.73e-05	0.000183	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GGT1—obesity	2.71e-05	0.000182	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GOT1—obesity	2.71e-05	0.000182	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—CCL2—obesity	2.68e-05	0.00018	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—NCOA1—obesity	2.67e-05	0.00018	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SDC3—obesity	2.67e-05	0.000179	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CYP2E1—obesity	2.64e-05	0.000177	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—IGF1—obesity	2.64e-05	0.000177	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—STK11—obesity	2.64e-05	0.000177	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CYP19A1—obesity	2.64e-05	0.000177	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—NQO1—obesity	2.61e-05	0.000175	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—STS—obesity	2.61e-05	0.000175	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—HK2—obesity	2.61e-05	0.000175	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYP26B1—obesity	2.61e-05	0.000175	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—SLC2A4—obesity	2.6e-05	0.000175	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—CYCS—obesity	2.57e-05	0.000173	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—obesity	2.55e-05	0.000172	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PPARD—obesity	2.55e-05	0.000171	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—obesity	2.53e-05	0.00017	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—obesity	2.52e-05	0.000169	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GCG—obesity	2.5e-05	0.000168	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—SLC2A4—obesity	2.5e-05	0.000168	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SLC27A1—obesity	2.5e-05	0.000168	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—NCOA1—obesity	2.49e-05	0.000167	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CYCS—obesity	2.47e-05	0.000166	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—COMT—obesity	2.45e-05	0.000165	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—FABP4—obesity	2.45e-05	0.000165	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GLUL—obesity	2.45e-05	0.000165	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GOT1—obesity	2.42e-05	0.000163	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GGT1—obesity	2.42e-05	0.000163	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—PLG—obesity	2.42e-05	0.000163	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PPARGC1A—obesity	2.42e-05	0.000162	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GNB3—obesity	2.42e-05	0.000162	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—HMOX1—obesity	2.4e-05	0.000162	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—NCOA1—obesity	2.39e-05	0.00016	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GNAS—obesity	2.35e-05	0.000158	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—STK11—obesity	2.35e-05	0.000158	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CYP19A1—obesity	2.35e-05	0.000158	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—UCP2—obesity	2.32e-05	0.000156	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ECHS1—obesity	2.32e-05	0.000156	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—HSD11B1—obesity	2.32e-05	0.000156	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—UCP3—obesity	2.32e-05	0.000156	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—APOB—obesity	2.3e-05	0.000155	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ADH1B—obesity	2.29e-05	0.000154	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PPARGC1B—obesity	2.25e-05	0.000151	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GPAM—obesity	2.25e-05	0.000151	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ACSL1—obesity	2.25e-05	0.000151	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—GNB3—obesity	2.25e-05	0.000151	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—HMOX1—obesity	2.23e-05	0.00015	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—LPL—obesity	2.2e-05	0.000148	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—GNAS—obesity	2.19e-05	0.000147	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—COMT—obesity	2.19e-05	0.000147	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—HADH—obesity	2.18e-05	0.000147	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PCK1—obesity	2.18e-05	0.000147	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—FADS1—obesity	2.18e-05	0.000147	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GNB3—obesity	2.16e-05	0.000145	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PPARGC1A—obesity	2.16e-05	0.000145	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GPX1—obesity	2.15e-05	0.000144	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—HMOX1—obesity	2.15e-05	0.000144	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—obesity	2.14e-05	0.000144	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—APOB—obesity	2.14e-05	0.000144	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—obesity	2.14e-05	0.000144	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ACP5—obesity	2.12e-05	0.000143	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GNAS—obesity	2.1e-05	0.000141	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CD36—obesity	2.09e-05	0.00014	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—G6PD—obesity	2.07e-05	0.000139	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—APOB—obesity	2.06e-05	0.000138	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SREBF2—obesity	2.04e-05	0.000137	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—HK1—obesity	2.04e-05	0.000137	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—obesity	2e-05	0.000134	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—MTHFR—obesity	1.98e-05	0.000133	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—LPA—obesity	1.97e-05	0.000133	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—LPL—obesity	1.96e-05	0.000132	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PPARA—obesity	1.94e-05	0.000131	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—LPIN1—obesity	1.93e-05	0.00013	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GPX1—obesity	1.91e-05	0.000129	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—APOA5—obesity	1.89e-05	0.000127	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—AGT—obesity	1.88e-05	0.000126	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CD36—obesity	1.86e-05	0.000125	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—APOE—obesity	1.84e-05	0.000124	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CAV1—obesity	1.83e-05	0.000123	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—APOA1—obesity	1.82e-05	0.000122	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—obesity	1.82e-05	0.000122	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SLC22A1—obesity	1.81e-05	0.000121	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CLOCK—obesity	1.81e-05	0.000121	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—PPARA—obesity	1.81e-05	0.000121	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—MTHFR—obesity	1.77e-05	0.000119	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GLP1R—obesity	1.76e-05	0.000118	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SULT2A1—obesity	1.76e-05	0.000118	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.75e-05	0.000117	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PPARA—obesity	1.73e-05	0.000116	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—DPYD—obesity	1.73e-05	0.000116	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—APOA1—obesity	1.69e-05	0.000114	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—AGT—obesity	1.68e-05	0.000113	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PRKAR2B—obesity	1.67e-05	0.000112	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PIK3CG—obesity	1.66e-05	0.000112	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—DCN—obesity	1.65e-05	0.000111	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—APOE—obesity	1.64e-05	0.000111	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CAV1—obesity	1.63e-05	0.000109	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—APOA1—obesity	1.63e-05	0.000109	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CPT1A—obesity	1.61e-05	0.000108	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PPARG—obesity	1.61e-05	0.000108	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—POMC—obesity	1.58e-05	0.000106	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—NAMPT—obesity	1.58e-05	0.000106	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—INS—obesity	1.58e-05	0.000106	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—LIPC—obesity	1.57e-05	0.000105	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GCK—obesity	1.57e-05	0.000105	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—APOC3—obesity	1.56e-05	0.000105	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.56e-05	0.000105	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CETP—obesity	1.51e-05	0.000102	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SDC1—obesity	1.5e-05	0.000101	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—obesity	1.49e-05	9.98e-05	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PIK3CG—obesity	1.48e-05	9.97e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—AKR1C3—obesity	1.47e-05	9.89e-05	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PIK3CD—obesity	1.46e-05	9.83e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SCARB1—obesity	1.45e-05	9.74e-05	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ALB—obesity	1.44e-05	9.7e-05	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PPARG—obesity	1.43e-05	9.63e-05	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—POMC—obesity	1.41e-05	9.49e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SREBF1—obesity	1.41e-05	9.45e-05	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—INS—obesity	1.41e-05	9.44e-05	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PIK3R1—obesity	1.38e-05	9.28e-05	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—NOS3—obesity	1.38e-05	9.28e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GOT2—obesity	1.37e-05	9.2e-05	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—ALB—obesity	1.34e-05	9.02e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—FASN—obesity	1.34e-05	9e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—BCHE—obesity	1.33e-05	8.96e-05	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PIK3CD—obesity	1.3e-05	8.77e-05	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ALB—obesity	1.29e-05	8.66e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYP2E1—obesity	1.29e-05	8.65e-05	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PIK3CB—obesity	1.27e-05	8.57e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—NQO1—obesity	1.27e-05	8.55e-05	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PTGS2—obesity	1.26e-05	8.49e-05	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PIK3R1—obesity	1.23e-05	8.28e-05	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—NOS3—obesity	1.23e-05	8.28e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GCG—obesity	1.22e-05	8.2e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SLC2A4—obesity	1.22e-05	8.2e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYCS—obesity	1.2e-05	8.09e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GGT1—obesity	1.18e-05	7.94e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GOT1—obesity	1.18e-05	7.94e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—NCOA1—obesity	1.16e-05	7.82e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—STK11—obesity	1.15e-05	7.71e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYP19A1—obesity	1.15e-05	7.71e-05	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PIK3CB—obesity	1.14e-05	7.64e-05	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PTGS2—obesity	1.13e-05	7.57e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—COMT—obesity	1.07e-05	7.17e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PPARGC1A—obesity	1.05e-05	7.07e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GNB3—obesity	1.05e-05	7.07e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—HMOX1—obesity	1.05e-05	7.03e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GNAS—obesity	1.02e-05	6.88e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—APOB—obesity	1e-05	6.74e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—LPL—obesity	9.57e-06	6.43e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GPX1—obesity	9.34e-06	6.28e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CD36—obesity	9.1e-06	6.11e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—MTHFR—obesity	8.62e-06	5.79e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PPARA—obesity	8.46e-06	5.68e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—AGT—obesity	8.19e-06	5.5e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—APOE—obesity	8.03e-06	5.39e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CAV1—obesity	7.95e-06	5.34e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—APOA1—obesity	7.93e-06	5.33e-05	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PIK3CA—obesity	7.77e-06	5.22e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PIK3CG—obesity	7.24e-06	4.87e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PPARG—obesity	6.99e-06	4.7e-05	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PIK3CA—obesity	6.93e-06	4.66e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—POMC—obesity	6.89e-06	4.63e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—INS—obesity	6.86e-06	4.61e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PIK3CD—obesity	6.37e-06	4.28e-05	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—AKT1—obesity	6.35e-06	4.27e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ALB—obesity	6.29e-06	4.22e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PIK3R1—obesity	6.01e-06	4.04e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—NOS3—obesity	6.01e-06	4.04e-05	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—AKT1—obesity	5.66e-06	3.81e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PIK3CB—obesity	5.55e-06	3.73e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PTGS2—obesity	5.5e-06	3.69e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PIK3CA—obesity	3.38e-06	2.27e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—AKT1—obesity	2.76e-06	1.86e-05	CbGpPWpGaD
